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Aim
There are growing evidences that tumors contain a sub-
set of cells with stem like properties. These cells are
referred as cancer stem cells (CSC) and are responsible
for driving tumor growth and recurrence. We aimed to
isolate and characterize putative CSCs in a human
osteosarcoma cell line (MNNG/HOS) and to explore
their role in response to chemotherapy.
Methods
CSCs were isolated using the sphere-forming assay in
serum-free medium under non-adherent conditions and
characterized for the expression of mesenchymal stem
cell markers (CD90
+, CD105
+,C D 7 3
+) by flow cytome-
try. The chemosensitity of MNNG and CSCs to doxoru-
bicin (DOX), cisplatin (CIS) and methotrexate (MTX)
was evaluated using the MTT colorimetric assay after
an incubation period of 48h. Cell cycle progression was
analyzed by flow cytometry with propidiun iodide.
Results
A subpopulation of tumor cells formed sphere-clusters
in serum-free medium and were positive for MSC mar-
kers. These cells revealed to be more resistant to che-
motherapy in comparison with MNNG/HOS cells. The
half maximal inhibitory concentrations (IC50)o fD O X
(0.66 ± 0.24 μM), CIS (13.18 ± 0.09 μM) and MTX
(0.05 ± 0.01 μM) were significantly higher (p < 0.05)
than those in MNNG/HOS cells (DOX: 0.30 ± 0.07 μM;
CIS: 8.08 ± 3.78 μM; MTX: 0.006 ± 0.001 μM). All
drugs induced a G2/M cell cycle arrest in MNNG/HOS
cells. In opposite, no significant changes were observed
in CSC.
Conclusions
We have identified a subset of tumor cells with stem-
like properties in OS that are relatively resistant to
conventional chemotherapeutic agents. Therefore con-
v e n t i o n a ld r u g sm i g h tn o ta d d r e s st h i ss u b s e to fc e l l s
that can be responsible for tumor regrowth after
therapy.
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